🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs cnbc.com/2024/08/13/ro-…

Introducing the GLP-1 Insurance Coverage Checker – a free tool that empowers anyone to easily check if their insurance covers GLP-1s medications and understand their potential OOP costs at the very beginning of their journey. ro.co/weight-loss/gl…

Checking GLP-1 drug insurance coverage just got a little easier, thanks to a new tool from Ro. CEO Z Reitano explains how it works. He also gives his read on the blockbuster obesity drug market.

At Ro, we are rooting for the GLP-1 shortages to end ASAP. Since introducing our GLP-1 Supply Tracker three months ago though, we've received over 60k drug shortage reports. Dive into our latest blog to learn what this data reveals about the shortages: ro.co/news/glp1-supp…

Thanks for standing tall, shannon sharpe. You're not the only one getting it in - we created Ro Sparks to help millions of guys do the act. We got you 💪

How can people maintain muscle while on GLP-1s? Our team and advisors, Beverly G. Tchang, MD & Dr. David Allison, delve into the relationship between weight loss and muscle mass + strength, plus share insights on maintaining both with lifestyle interventions. ro.co/perspectives/g…

Ro has conducted benefits verifications for patients nationwide. Our insights reveal that there is still so much more to be done to help patients access high-quality obesity care – from increasing ins. coverage to removing roadblocks to care. #ObesityCareNOW

We appreciate the Senate HELP Committee's focus on expanding access to GLP-1 medications, such as Ozempic and Wegovy, for more patients. Beyond those paying cash or without insurance, our data shows that even patients with coverage can face high costs.

Washington Spirit Sara Fischer Catch Ro CEO Z Reitano at in conversation with Dan Primack at #AxiosBFD in New York. Tune in tomorrow at 2:50pm ET

Tune in at 2:50PM ET to catch Ro CEO, Z Reitano chat with @Axios' Dan Primack about the impact of GLP-1s on the healthcare system and beyond at #AxiosBFD! youtube.com/watch?v=K5_vjR…

Patients come to Ro for the care they need to live happier, more fulfilled lives. Today, we’re sharing research highlighting the many ways accessing obesity care through Ro can change lives: ro.co/weight-loss/qu…

1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. endpts.com/ros-weight-los… ➡️ Avg weight loss: 15.8% after 12 months on GLP-1s ➡️ 80% of patients with metabolic risks improved their lab results

Ro is working with Eli Lilly and Company! Through a first-of-its-kind integration with LillyDirect, Zepbound single-dose vials are now available through Ro – offering a seamless obesity care experience bringing together telehealth, lab, and pharmacy services. cnbc.com/2024/12/11/ro-…

$LLY lowering the price of the vials! $349 for 2.5 and $499 for higher doses on monthly orders. Big win for patients! Also… they’re in stock (always have been since launch). Proud to offer seamless access via @Ro in unique integration with Eli Lilly and Company

Today, Ro is announcing a collaboration with Novo Nordisk — starting with an integration with NovoCare® Pharmacy. Fighting for patients means making it as easy and affordable as possible to access high-quality treatment, and that’s what Ro and Novo aim to do.

Some *BIG* news from the team Ro today — we're thrilled to announce a new partnership with the one and only Charles Barkley! 🏀 As we got to know Charles through this process, it became clear how personally meaningful this subject is to him — even beyond his own weight loss

A new deal between @Ro and $NVO allows patients to get its flagship weight loss drug Wegovy for as low as $499 per month CEO Z Reitano breaks down the details of the deal and what it means for patients cnb.cx/4jvFofs

Curious if your insurance covers GLP-1s? Ro’s Insurance Coverage Checker has helped hundreds of thousands. Now, we're revealing key insights in our new report on GLP-1 access. Read the full report: ro.co/weight-loss/co…

Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy® for $199 plus their first month of the Ro Body membership for just $45.